SOLIDUS Trademark

Trademark Overview

On Tuesday, February 7, 2023, a trademark application was filed for SOLIDUS with the United States Patent and Trademark Office. The USPTO has given the SOLIDUS trademark a serial number of 97784560. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, October 15, 2025. This trademark is owned by Praxis Precision Medicines, Inc.. The SOLIDUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurological disorders and central nervous system disorders
solidus

General Information

Serial Number97784560
Word MarkSOLIDUS
Filing DateTuesday, February 7, 2023
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, October 15, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 17, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of neurological disorders and central nervous system disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 27, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePraxis Precision Medicines, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02110
Party NamePraxis Precision Medicines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02110

Trademark Events

Event DateEvent Description
Thursday, September 7, 2023EXAMINERS AMENDMENT E-MAILED
Friday, February 10, 2023NEW APPLICATION ENTERED
Monday, February 27, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 5, 2023ASSIGNED TO EXAMINER
Thursday, September 7, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, September 7, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, September 7, 2023EXAMINER'S AMENDMENT ENTERED
Friday, September 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 12, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 6, 2024DIVISIONAL REQUEST RECEIVED
Tuesday, October 17, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, June 6, 2024SOU EXTENSION 1 FILED
Sunday, July 21, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 6, 2024SOU TEAS EXTENSION RECEIVED
Thursday, June 6, 2024TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, July 23, 2024DIVISIONAL PROCESSING COMPLETE
Tuesday, July 23, 2024CORRECTED NOA E-MAILED
Tuesday, July 23, 2024SOU EXTENSION 1 GRANTED
Friday, November 15, 2024SOU EXTENSION 2 FILED
Friday, November 15, 2024SOU TEAS EXTENSION RECEIVED
Monday, November 18, 2024SOU EXTENSION 2 GRANTED
Monday, November 18, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 2, 2025SOU EXTENSION 3 FILED
Wednesday, October 15, 2025SOU EXTENSION 3 GRANTED
Wednesday, October 15, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 2, 2025SOU TEAS EXTENSION RECEIVED

Related Keywords

solidus disorders central system nervous neurological preparations treatment pharmaceutical